Warner Chilcott has received approval from the Food and Drug Administration for Minastrin 24 FE capsules, an oral contraceptive.


Warner Chilcott, Minastrin 24 FE, oral contraceptive, norethindrone acetate and ethinyl estradiol capsules, ferrous fumarate capsules, birth control pill




























































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

FDA approves Warner Chilcott birth control pill

April 22nd, 2013

DUBLIN, Ireland – Warner Chilcott has received approval from the Food and Drug Administration for Minastrin 24 FE capsules, an oral contraceptive.

The Ireland-based pharmaceutical company said Monday that it doesn't expect to launch Minastrin 24 FE (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) commercially this year.

Minastrin 24 FE is indicated for use by women of reproductive age to prevent pregnancy.

The FDA approval was the second that Warner Chilcott has announced in about a week. On April 12, the company said it plans to release Doryx delayed-release tablets (200 mg), an antibiotic, this summer.

Advertisement